{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:33:15Z","timestamp":1762101195050},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[1997,11]]},"abstract":"<jats:p>\n            <jats:italic>Background and Purpose<\/jats:italic>\n            The purpose of this study was to test the hypothesis that the neuroprotective compound CP101,606 will ameliorate the increase in lactate, retard the development of cytotoxic edema, and decrease the infarct volume after ischemic stroke.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods<\/jats:italic>\n            Seventeen adult cats were allocated to control (n=7) and CP101,606-treated groups (n=10). Transorbital middle cerebral artery occlusion was performed under anesthesia. Extracellular fluid lactate by microdialysis as well as infarct volume measurement by triphenyltetrazolium chloride (TTC)\u2013stained section, with and without neuroprotective agents, was used to determine the value of these potential \u201csurrogate markers\u201d of ischemic damage.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Results<\/jats:italic>\n            The control group showed an increased dialysate lactate (15.5% increase) at 30 minutes and a peak (332.0% increase) in dialysate lactate at 1 hour after middle cerebral artery occlusion compared with the drug-treated group. Significant differences between control and drug-treated groups were seen in the rate of fall of the apparent diffusion coefficient at both 1 and 5 hours. A close correlation was seen between the 1- and 5-hour apparent diffusion coefficient maps and the TTC-stained sections. There was a significantly smaller lesion in the CP101,606-treated group (62.9% reduction in infarct size compared with the control group;\n            <jats:italic>P<\/jats:italic>\n            &lt;.001).\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            CP101,606 ranks very highly among the current neuroprotection candidates for clinical trials, and its excellent safety record in both animals and phase II studies in conscious, moderate head injury patients suggests that it will be highly effective in human occlusive stroke.\n          <\/jats:p>","DOI":"10.1161\/01.str.28.11.2244","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T20:08:03Z","timestamp":1308341283000},"page":"2244-2251","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":45,"title":["Effect of CP101,606, a Novel NR2B Subunit Antagonist of the\n            <i>N<\/i>\n            -Methyl-\n            <scp>d<\/scp>\n            -Aspartate Receptor, on the Volume of Ischemic Brain Damage and Cytotoxic Brain Edema After Middle Cerebral Artery Occlusion in the Feline Brain"],"prefix":"10.1161","volume":"28","author":[{"given":"Xiao","family":"Di","sequence":"first","affiliation":[{"name":"From the Divisions of Neurosurgery (X.D., R.B., J.W.) and Radiation Biology (P.F., F.C.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Va, and Pfizer Central Research, Groton, Ct (B.C., F.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Bullock","sequence":"additional","affiliation":[{"name":"From the Divisions of Neurosurgery (X.D., R.B., J.W.) and Radiation Biology (P.F., F.C.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Va, and Pfizer Central Research, Groton, Ct (B.C., F.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Watson","sequence":"additional","affiliation":[{"name":"From the Divisions of Neurosurgery (X.D., R.B., J.W.) and Radiation Biology (P.F., F.C.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Va, and Pfizer Central Research, Groton, Ct (B.C., F.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panos","family":"Fatouros","sequence":"additional","affiliation":[{"name":"From the Divisions of Neurosurgery (X.D., R.B., J.W.) and Radiation Biology (P.F., F.C.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Va, and Pfizer Central Research, Groton, Ct (B.C., F.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Chenard","sequence":"additional","affiliation":[{"name":"From the Divisions of Neurosurgery (X.D., R.B., J.W.) and Radiation Biology (P.F., F.C.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Va, and Pfizer Central Research, Groton, Ct (B.C., F.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frost","family":"White","sequence":"additional","affiliation":[{"name":"From the Divisions of Neurosurgery (X.D., R.B., J.W.) and Radiation Biology (P.F., F.C.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Va, and Pfizer Central Research, Groton, Ct (B.C., F.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Corwin","sequence":"additional","affiliation":[{"name":"From the Divisions of Neurosurgery (X.D., R.B., J.W.) and Radiation Biology (P.F., F.C.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Va, and Pfizer Central Research, Groton, Ct (B.C., F.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1993.11"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-12-992"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)91473-T"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1991.tb00765.x"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Chen M Bullock R Graham DI Frey P Lowe D McCulloch J. Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia. Ann Neurol. 1991;30(1):62-70.","DOI":"10.1002\/ana.410300112"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1990.120"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240411"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1994.57"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00552-4"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.08-01-00185.1988"},{"key":"e_1_3_2_11_2","first-page":"73","volume":"57","year":"1993","unstructured":"McCulloch J, Ozyurt E, Park CK, Nehls DG, Teasdale GM, Graham DI. Glutamate receptor antagonists in experimental focal cerebral ischaemia. Acta Neurochir Suppl (Wien). 1993;57:73-79.","journal-title":"Acta Neurochir Suppl (Wien)"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.14-10-06102.1994"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)90677-7"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00016a017"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1471-4159.1996.66020692.x","volume":"66","year":"1996","unstructured":"Portera-Cailliau C, Price DL, Martin LJ. N-Methyl-D-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies. J Neurochem. 1996;66:692-700.","journal-title":"J Neurochem"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Lassen NA. Pathophysiology of brain ischemia as it relates to the therapy of acute ischemic stroke. Clin Neuropharmacol. 1990;13(suppl 3):S1-S8.","DOI":"10.1097\/00002826-199013003-00001"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.23.5.1579965"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910190206"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00690469"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.25.2.8303762"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910340607"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1996.84.1.0097"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1995.1"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.1940080708"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910300307"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-199511000-00027"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.26.4.667"},{"key":"e_1_3_2_28_2","first-page":"207","volume":"60","year":"1994","unstructured":"Jones S, Perez-Trepichio A, Xue M, Furlan A, Awad I. Magnetic resonance diffusion-weighted imaging: sensitivity and apparent diffusion constant in stroke. Acta Neurochir Suppl (Wien). 1994;60:207-210.","journal-title":"Acta Neurochir Suppl (Wien)"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1994.49"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(94)00258-4"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(87)90041-0"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1992.76.1.0072"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02098880"},{"key":"e_1_3_2_34_2","unstructured":"Bullock R McCulloch J Graham DI Lowe D Chen MH TeasdaleGM. Focal ischemic damage is reduced by CPP-ene studies in two animal models. Stroke. 1990;21(suppl III):III-32-III-36."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1988.18"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.28.11.2244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T22:12:14Z","timestamp":1715551934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.28.11.2244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["10.1161\/01.STR.28.11.2244"],"URL":"https:\/\/doi.org\/10.1161\/01.str.28.11.2244","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]},"assertion":[{"value":"1997-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-08-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}